Drug intelligence / Profile preview

Huaiqihuang

Development stage
Phase 4
Lead developer
Jianmin Pharmaceutical Group
Administration
Oral
01

Overview

Huaiqihuang is a Traditional Chinese Medicine (TCM) formulation composed of *Trametes robiniophila* Murr (Huaier), *Lycium barbarum* (Gouqi), and *Polygonatum sibiricum* (Huangjing). It is primarily used as an immunomodulatory adjuvant therapy for pediatric and adult immune-mediated conditions, including IgA nephropathy, systemic lupus erythematosus (SLE), and chronic immune thrombocytopenia (CITP). The formulation works by balancing inflammatory cytokines, specifically reducing B-cell activating factor (BAFF), interleukin-10 (IL-10), and monocyte chemoattractant protein 1 (MCP-1), while increasing interleukin-2 (IL-2) levels. Clinical studies have demonstrated its efficacy in reducing proteinuria, lowering disease activity scores, and decreasing recurrence rates in autoimmune disorders.

Brand names
Huaiqihuang
Other names
Huaiqihuang granulesHuai Qi Huang
02

Targets

IL10 (Interleukin-10)BAFF (Tumor necrosis factor ligand superfamily member 13B)IL-2 (Interleukin 2)

Beyond the preview

Go deeper on Huaiqihuang.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Huaiqihuang.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call